These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38387480)

  • 1. Preservation of β-Cells as a Therapeutic Strategy for Diabetes.
    Taneera J; Saber-Ayad MM
    Horm Metab Res; 2024 Apr; 56(4):261-271. PubMed ID: 38387480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors: impact on glucose metabolism.
    Boj-Carceller D
    Endocrine; 2013 Feb; 43(1):22-32. PubMed ID: 22886351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating pancreatic beta-like cells from human pluripotent stem cells.
    Lim LY; Ching C; Kong D; Chan SY; Teo AKK
    Methods Cell Biol; 2022; 170():127-146. PubMed ID: 35811096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
    Murakami T; Inagaki N; Kondoh H
    Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of physical exercise for β-cell maintenance in a type 1 diabetes mellitus animal model.
    Villaça CBP; de Paula CC; de Oliveira CC; Vilas-Boas EA; Dos Santos-Silva JC; de Oliveira SF; Abdulkader F; Ferreira SM; Ortis F
    Exp Physiol; 2021 Jul; 106(7):1482-1497. PubMed ID: 33913203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
    Yang CH; Ann-Onda D; Lin X; Fynch S; Nadarajah S; Pappas EG; Liu X; Scott JW; Oakhill JS; Galic S; Shi Y; Moreno-Asso A; Smith C; Loudovaris T; Levinger I; Eizirik DL; Laybutt DR; Herzog H; Thomas HE; Loh K
    Mol Metab; 2022 Jan; 55():101413. PubMed ID: 34890851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte DH; Verchere CB
    Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating LncRNAs Analysis in Patients with Type 2 Diabetes Reveals Novel Genes Influencing Glucose Metabolism and Islet β-Cell Function.
    Ruan Y; Lin N; Ma Q; Chen R; Zhang Z; Wen W; Chen H; Sun J
    Cell Physiol Biochem; 2018; 46(1):335-350. PubMed ID: 29590649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAG-1/GDF15 protects against streptozotocin-induced type 1 diabetes by inhibiting apoptosis, preserving beta-cell function, and suppressing inflammation in pancreatic islets.
    Wang Y; Chen J; Sang T; Chen C; Peng H; Lin X; Zhao Q; Chen S; Eling T; Wang X
    Mol Cell Endocrinol; 2022 Jun; 549():111643. PubMed ID: 35398052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management.
    Dinić S; Arambašić Jovanović J; Uskoković A; Mihailović M; Grdović N; Tolić A; Rajić J; Đorđević M; Vidaković M
    Front Endocrinol (Lausanne); 2022; 13():1006376. PubMed ID: 36246880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.
    Ardestani A; Maedler K
    Diabetologia; 2016 Sep; 59(9):1843-9. PubMed ID: 27053234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet β cell mass in diabetes and how it relates to function, birth, and death.
    Weir GC; Bonner-Weir S
    Ann N Y Acad Sci; 2013 Apr; 1281(1):92-105. PubMed ID: 23363033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-cell replenishment: Possible curative approaches for diabetes mellitus.
    Rathwa N; Patel R; Palit SP; Parmar N; Rana S; Ansari MI; Ramachandran AV; Begum R
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1870-1881. PubMed ID: 32994121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing CXCL12 signaling to protect and preserve functional β-cell mass and for cell replacement in type 1 diabetes.
    Alagpulinsa DA; Cao JJL; Sobell D; Poznansky MC
    Pharmacol Ther; 2019 Jan; 193():63-74. PubMed ID: 30149101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats.
    Sadek KM; Shaheen H
    Pharm Biol; 2014 May; 52(5):591-6. PubMed ID: 24251869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
    Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
    Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.